SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The mission of the Worldcoin project is to build the world’s largest identity and financial network as a public utility, giving ownership to everyone. A key component of the Worldcoin project is the development of the foundational infrastructure that will be important for a world where AI plays an increasingly large role.  The Worldcoin system revolves around World ID, a privacy-preserving global identity network. World ID enables users to verify their humanness online while maintaining their privacy through zero-knowledge proofs.  Using World ID, individuals will be able to prove that they are a real, unique human to any platform that integrates with the protocol, including to web3 systems, social networking sites, and governmental programs. This will enable fair airdrops or token/NFT sales, provide protection against bots/sybil attacks on social media, and enable the fairer distribution of limited governmental resources. Furthermore, World ID can also enable global democratic processes and novel forms of governance (e.g., via quadratic voting), and it may eventually show a path to AI-funded UBI. The Worldcoin token (WLD), alongside World ID, will let users participate in governing the Worldcoin protocol.   To engage with the Worldcoin protocol, individuals must first download a first wallet app that supports the creation of a World ID. Users visit a physical imaging device called the Orb to get their World ID Orb-verified. Orbs are operated by a network of independent local businesses called Orb Operators. The Orb uses multispectral sensors to verify humanness and uniqueness to issue an Orb-verified World ID, with all images being promptly deleted on-device per default (absent explicit consent to Data Custody). All Orb-verified World IDs holders are entitled to claim recurring grants of free WLD tokens, subject to certain availability restrictions. The WLD token is designed as a utility token with governance properties.

Worldcoin

Worldcoin is experiencing intense community interest driven by its integration into Sam Altmans broader AI and digital identity ecosystem, with investors closely watching treasury accumulation strategies by firms like Eightco Holdings. Enthusiasts are actively debating its potential as a critical "proof-of-humanity" solution in an AI-dominated landscape, leading to high volatility and aggressive retail participation.

The Render Network is a leading decentralized GPU compute platform for applications ranging from 3D rendering to machine learning and generative AI.  The network connects node operators looking to monetize their idle GPU compute power with artists and developers looking to scale intensive 3D rendering work and machine learning applications in the cloud. Through a decentralized peer-to-peer network, the Render Network achieves unprecedented levels of scale, speed, and economic efficiency. Facilitated by the Render Network Foundation, the ecosystem empowers artists and developers to build services and applications for the emerging digital economy.

Render Token (SOL)

Render Token is attracting significant attention as investors position themselves for the decentralized AI compute and DePIN sectors, with many citing its utility and potential for long-term growth as key drivers. While some in the community remain skeptical, bullish sentiment is fueled by active discussions around the network's efficiency and its critical role in powering the expanding AI application ecosystem.

AXT, Inc. engages in the design, development, manufacture and distribution of compound and single element semiconductor substrates. It also sells specialty material substrates and raw materials used to make substrates and other related products. The company was founded by Morris S. Young and Davis Zhang in 1986 and is headquartered in Fremont, CA.

AXT Inc

AXT Inc. is currently seeing volatile trading and significant community attention as speculative traders debate whether the stock is a long-term play on semiconductor and AI photonics infrastructure or an overextended pump-and-dump scheme. While bulls point to critical demand for Indium Phosphide in data centers and high-speed optics, bears cite ongoing concerns about the company's profitability, reliance on Chinese manufacturing, and the potential for imminent stock offerings to dilute current shareholders.

Bittensor is an open-source protocol that powers a decentralized, blockchain-based machine learning network. Machine learning models train collaboratively and are rewarded in TAO according to the informational value they offer the collective. TAO also grants external access, allowing users to extract information from the network while tuning its activities to their needs.  Ultimately, BitTensors vision is to create a pure market for artificial intelligence, an incentivized arena in which consumers and producers of this valuable commodity can interact in a trustless, open and transparent context.  Bittensor enables:  -A novel, optimized strategy for the development and distribution of artificial intelligence technology by leveraging the possibilities of a distributed ledger. Specifically, its facilitation of open access/ownership, decentralized governance, and the ability to harness globally-distributed resources of computing power and innovation within an incentivized framework.  -An open-source repository of machine intelligence, accessible to anyone, anywhere, thus creating the conditions for open and permission-less innovation on a global internet scale.  -Distribution of rewards and network ownership to users in direct proportion to the value they have added.

Bittensor

Bittensor (TAO) is generating significant momentum as the community highlights its Bitcoin-inspired scarcity, upcoming halving event, and pivotal role in decentralized AI infrastructure. Investors are actively discussing the coin's growth potential alongside new institutional interest from Grayscale's recent ETF filing and subnet-based ecosystem development.

Scilex Holding Co. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. Its products include ZTLido, Elyxyb, and Gloperba. The company was founded on February 21, 2020 and is headquartered in Palo Alto, CA.

Scilex Holding Company

Scilex Holding Company is currently trending due to a recently unsealed federal lawsuit against BNY Mellon and other entities, which alleges a fraudulent scheme involving the unauthorized sale of pledged DVLT shares as collateral. The community is sharply divided, with some investors viewing the litigation as a necessary step to protect corporate assets and initiate a potential short squeeze, while others remain highly critical of leadership, citing a history of failed partnerships and questioning the transparency of these financial maneuvers.

Air Canada engages in the provision of airline transportation services. Its services cover full-service airline, scheduled passenger and cargo services, serving more than two hundred airports on six continents. It operates through the following geographical segments: Canada, U.S. Transborder, Atlantic, Pacific, and Other. The company was founded on April 11, 1936 and is headquartered in Saint-Laurent, Canada.

Air Canada Inc. - Ordinary Shares (Voting and Variable Voting)

Air Canada Inc.

Air Canada is experiencing intense community debate, with investors closely watching a new share buyback program and arbitration developments while navigating ongoing concerns regarding high fuel costs and geopolitical instability. The stock remains a focal point for both long-term holders eyeing potential growth through fleet modernization and short-term traders reacting to fluctuating energy prices and market sentiment.

MGM Resorts International is a holding company, which engages in the ownership and operations of casino resorts. The firm's casino resorts offer gaming, hotel, convention, dining, entertainment, retail, and other resort amenities. It operates through the following business segments: Las Vegas Strip Resorts, Regional Operations, MGM China, and MGM Digital. The Las Vegas Strip Resorts segment operates the following casino resorts: Bellagio, MGM Grand Las Vegas, Mandalay Bay, The Mirage, Luxor, New York-New, Excalibur, Park MGM, and Circus Las Vegas. The Regional Operations segment consists of the following casino resorts: MGM Grand Detroit in Detroit, Michigan, Beau Rivage in Biloxi, Mississippi, Gold Strike Tunica in Tunica, Mississippi, Borgata in Atlantic City, New Jersey, MGM National Harbor in Prince George’s County, Maryland, and MGM Springfield in Springfield, Massachusetts. The MGM China segment includes MGM Macau and MGM Cotai. The MGM Digital segment focuses on the online gaming portfolio, which consists primarily of Leo Vegas, which is headquartered in Sweden and Malta. The company was founded by Kerkor Kerkorian on January 29, 1986 and is headquartered in Las Vegas, NV.

MGM Resorts International

MGM Resorts is capturing market attention as investors weigh its robust recent earnings and positive forward guidance against broader sector concerns regarding shifting discretionary spending and potential regulatory headwinds. The community is actively debating the company's valuation relative to its digital growth initiatives in the iGaming space and its long-term expansion plans in international markets like Japan.

|The Artificial Superintelligence (ASI) Alliance is the world’s largest open-source initiative dedicated to decentralized Artificial General Intelligence (AGI). Formed in April 2024, the ASI Alliance unites SingularityNET, Fetch.ai, and Ocean Protocol, with CUDOS joining as a network member shortly after. The ASI Alliance was established through a community-approved tokenomic merger—combining $AGIX, $FET, and $OCEAN into a single token: $FET. This unified token underpins a collaborative framework designed to scale open-source AI and stand as the largest open-sourced, independent entity in AI research and development. The Alliance is committed to accelerating the advancement of decentralized Artificial General Intelligence (AGI) and, ultimately, Artificial Superintelligence (ASI). It provides a robust, open-source innovation stack, empowering developers, enterprises, and researchers globally to build ethical, scalable, and groundbreaking AI solutions. This ensures that advanced intelligence remains a shared, accessible resource, fostering innovation beyond centralized systems and promoting a future where AI benefits all.

Fetch.ai

Fetch.ai is trending as investors debate whether the current price levels represent a deep-value opportunity or a sign of further decline, fueled by recent community focus on its Agentic AI capabilities. Discussion is heavily polarized, with many users weighing the project's long-term potential in the decentralized AI sector against ongoing frustrations over market performance, token supply concerns, and recent FUD.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Merck is trending due to heightened M&A speculation following reports of collapsed buyout talks with Revolution Medicines, as investors monitor the company's strategy to offset the looming 2028 Keytruda patent cliff. Meanwhile, the community is actively debating Merck's oncology pipeline, including the progress of mRNA-4157 partnerships and the competitive threat posed by emerging immunotherapy platforms like Anktiva.

Direxion Shares ETF Trust - Direxion Daily Junior Gold Miners Index Bull 2X ETF

Direxion Daily Junior Gold Miners Index Bull 2X Shares

JNUG is trending as investors weigh the impact of escalated Middle East conflict and shifting energy market dynamics on gold mining valuations. The community is actively debating the potential for a technical bounce against risks of a deeper sector pullback amidst broader concerns about stagflation and government spending.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Corvus Pharmaceuticals (NASDAQ:CRVS) Lowered to "Sell" Rating by Wall Street Zen

Wall Street Zen lowered Corvus Pharmaceuticals from a "hold" rating to a "sell" rating in a report on Saturday...

Corvus Pharmaceuticals (NASDAQ:CRVS) Given Outperform Rating at Oppenheimer

Oppenheimer reiterated an "outperform" rating and set a $33.00 price target (up from $32.00) on shares of Corvus Pharmaceuticals in a report on Friday...

Corvus Pharmaceuticals (NASDAQ:CRVS) Shares Down 6.5% After Earnings Miss

Corvus Pharmaceuticals (NASDAQ:CRVS) Stock Price Down 6.5% After Earnings Miss...

Corvus Pharmaceuticals Q4 Earnings Call Highlights

Corvus Pharmaceuticals (NASDAQ:CRVS) outlined expanding clinical plans for its selective ITK inhibitor soquelitinib while reporting higher research and development spending for 2025, reflecting a...

Corvus Pharmaceuticals (NASDAQ:CRVS) Issues Earnings Results, Misses Expectations By $0.01 EPS

Corvus Pharmaceuticals (NASDAQ:CRVS - Get Free Report) posted its quarterly earnings data on Thursday. The company reported ($0.15) earnings per share (EPS) for the quarter, missing analysts...

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Given Average Recommendation of "Moderate Buy" by Brokerages

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the seven analysts that are presently covering the stock, MarketBeat Ratings...

Corvus Pharmaceuticals (CRVS) Projected to Post Quarterly Earnings on Thursday

Corvus Pharmaceuticals (NASDAQ:CRVS) will be releasing its Q4 2025 earnings before the market opens on Thursday, March 12. (View Earnings Report at...

Corvus Pharmaceuticals (NASDAQ:CRVS) Stock Price Down 9.4% - Here's Why

Corvus Pharmaceuticals (NASDAQ:CRVS) Shares Down 9.4% - Here's What Happened...

Corvus Pharmaceuticals Highlights Soquelitinib Pipeline, Eyes Phase II Atopic Dermatitis Trial in 2026

Corvus Pharmaceuticals (NASDAQ:CRVS) provided an update on its pipeline at Oppenheimer's Annual Healthcare Conference, with Chief Business Officer Jeff Arcara focusing primarily on soquelitinib, the...

Corvus Pharmaceuticals (NASDAQ:CRVS) Shares Down 7.6% - Time to Sell?

Corvus Pharmaceuticals (NASDAQ:CRVS) Trading Down 7.6% - Time to Sell...

$CRVS Q4 &#39;25 Earnings Results &amp; Recap

• Reported GAAP EPS of -$0.15 up 16.67% YoY
• Corvus Pharmaceuticals expects its existing cash, cash equivalents, and marketable securities, including proceeds from its January 2026 financing, to fund operations into the second quarter of 2028.

Stocktwits

Corvus Pharmaceuticals Inc

 Q4 '25 Earnings Results & Recap

• Reported GAAP EPS of -$0.15 up 16.67% YoY
• Corvus Pharmaceuticals expects its existing cash, cash equivalents, and marketable securities, including proceeds from its January 2026 financing, to fund operations into the second quarter of 2028.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

CRVS
Corvus Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Earnings Recap

Latest CRVS News

CRVSCorvus Pharmaceuticals Inc